Literature DB >> 10173772

Alzheimer's disease in the United Kingdom: developing patient and carer support strategies to encourage care in the community.

R Hunter1, L McGill, N Bosanquet, N Johnson.   

Abstract

Alzheimer's disease is a growing challenge for care providers and purchasers. With the shift away from the provision of long term institutional care in most developed countries, there is a growing tendency for patients with Alzheimer's disease to be cared for at home. In the United Kingdom, this change of direction contrasts with the policies of the 1980s and 90s which focused more attention on controlling costs than on assessment of the needs of the patient and carer and patient management. In recent years, the resources available for management of Alzheimer's disease have focused on institutional care, coupled with drug treatment to control difficult behaviour as the disease progresses. For these reasons, the current system has led to crisis management rather than preventive support--that is, long term care for a few rather than assistance in the home before the crises occur and institutional care is needed. Despite recent innovations in the care of patients with Alzheimer's disease, the nature of the support that patients and carers receive is poorly defined and sometimes inadequate. As a result of the shift towards care in the community, the informal carer occupies an increasingly central role in the care of these patients and the issue of how the best quality of care may be defined and delivered is an issue which is now ripe for review. The objective of this paper is to redefine the type of support that patients and carers should receive so that the disease can be managed more effectively in the community. The needs of patients with Alzheimer's disease and their carers are many and this should be taken into account in defining the quality and structure of healthcare support. This paper shows how new initiatives, combined with recently available symptomatic drug treatment, can allow patients with Alzheimer's disease to be maintained at home for longer. This will have the dual impact of raising the quality of care for patients and improving the quality of life for their carers. Moreover, maintaining patients in a home environment will tend to limit public and private expenditure on institutional care due to a possible delay in the need for it.

Entities:  

Mesh:

Year:  1997        PMID: 10173772      PMCID: PMC1055476          DOI: 10.1136/qshc.6.3.146

Source DB:  PubMed          Journal:  Qual Health Care        ISSN: 0963-8172


  15 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Psychotropic drug use among caregivers of patients with dementia.

Authors:  E C Clipp; L K George
Journal:  J Am Geriatr Soc       Date:  1990-03       Impact factor: 5.562

Review 3.  The prevalence of dementia: a quantitative integration of the literature.

Authors:  A F Jorm; A E Korten; A S Henderson
Journal:  Acta Psychiatr Scand       Date:  1987-11       Impact factor: 6.392

Review 4.  Potential effect of tacrine on expenditures for Alzheimer's disease.

Authors:  D P Lubeck; P D Mazonson; T Bowe
Journal:  Med Interface       Date:  1994-10

5.  Alzheimer's disease: the burden of the illness in England.

Authors:  A Gray; P Fenn
Journal:  Health Trends       Date:  1993

6.  The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group.

Authors:  S L Rogers; L T Friedhoff
Journal:  Dementia       Date:  1996 Nov-Dec

7.  Effect of a training programme to reduce stress in carers of patients with dementia.

Authors:  H Brodaty; M Gresham
Journal:  BMJ       Date:  1989-12-02

8.  Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group.

Authors:  W A Rocca; A Hofman; C Brayne; M M Breteler; M Clarke; J R Copeland; J F Dartigues; K Engedal; O Hagnell; T J Heeren
Journal:  Ann Neurol       Date:  1991-09       Impact factor: 10.422

9.  Caring for elderly dependents: effects on the carers' quality of life.

Authors:  D A Jones; T J Peters
Journal:  Age Ageing       Date:  1992-11       Impact factor: 10.668

Review 10.  The health of persons giving care to the demented elderly: a critical review of the literature.

Authors:  M Baumgarten
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

View more
  3 in total

1.  Formal consensus and consultation: a qualitative method for development of a guideline for dementia.

Authors:  H Trickey; I Harvey; G Wilcock; D Sharp
Journal:  Qual Health Care       Date:  1998-12

2.  A molecular approach to treating cognition in schizophrenia by calcium channel blockade: An open-label pilot study of the calcium-channel antagonist isradipine.

Authors:  Katherine E Burdick; Mercedes Perez-Rodriguez; Rebecca Birnbaum; Megan Shanahan; Emmett Larsen; Cierra Harper; Jessica Poskus; Pamela Sklar
Journal:  Schizophr Res Cogn       Date:  2020-05-18

Review 3.  Reviewing the definition of crisis in dementia care.

Authors:  Janet MacNeil Vroomen; Judith E Bosmans; Hein P J van Hout; Sophia E de Rooij
Journal:  BMC Geriatr       Date:  2013-02-01       Impact factor: 3.921

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.